Prognostic impact of lymphadenectomy in clinically early stage malignant germ cell tumour of the ovary.
Br. J. Cancer., Aug;105(4):493-7 (2011)
Suicide in women with gynecologic cancer.
Gynecol. Oncol., Aug;122(2):344-9 (2011)
Disparities in treatment and survival between African American and White women with vaginal cancer.
Gynecol. Oncol., Jul;122(1):38-41 (2011)
Pelvic exenteration in the age of modern chemoradiation.
Gynecol. Oncol., Apr;121(1):131-4 (2011)
FOXP3+ regulatory T-cells are abundant in vulvar Paget's disease and are associated with recurrence.
Gynecol. Oncol., Feb;120(2):296-9 (2011)
Ovarian cancer in the elderly: outcomes with neoadjuvant chemotherapy or primary cytoreduction.
Gynecol. Oncol., Jul;118(1):43-6 (2010)
Alternative intraperitoneal chemotherapy regimens for optimally debulked ovarian cancer.
Gynecol. Oncol., Mar;116(3):340-4 (2010)
An evaluation of cervical cancer in women age sixty and over.
Gynecol. Oncol., Apr;109(1):53-8 (2008)
Kinetics of tumor-specific T-cell response development after active immunization in patients with HER-2/neu overexpressing cancers.
Clin. Immunol., Dec;125(3):275-80 (2007)
Antibody immunity to the p53 oncogenic protein is a prognostic indicator in ovarian cancer.
J. Clin. Oncol., Feb;24(5):762-8 (2006)
Weekly gemcitabine and cisplatin in combination with pelvic radiation in the primary therapy of cervical cancer: a phase I trial of the Puget Sound Oncology Consortium.
Gynecol. Oncol., Jun;101(3):429-35 (2006)
Surgery for ovarian cancer: rationale and guidelines.
J Natl Compr Canc Netw., Nov;2(6):561-8 (2004)
Obstetrics and gynecology: avoiding pregnancy in isotretinoin users.
West. J. Med., Apr;152(4):406 (1990)